• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Reliance Global Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

    2/10/26 9:00:45 AM ET
    $EZRA
    Specialty Insurers
    Finance
    Get the next $EZRA alert in real time by email
    false 0001812727 0001812727 2026-02-05 2026-02-05 0001812727 RELI:CommonStockParValue0.086PerShareMember 2026-02-05 2026-02-05 0001812727 RELI:SeriesWarrantsToPurchaseSharesOfCommonStockParValue0.086PerShareMember 2026-02-05 2026-02-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): February 5, 2026

     

    RELIANCE GLOBAL GROUP, INC.

    (Exact Name of Registrant as Specified in Its Charter)

     

    Florida   001-40020   46-3390293
    (State or Other Jurisdiction
    of Incorporation)
      (Commission
    File Number)
      (IRS Employer
    Identification No.)

     

    300 Blvd. of the Americas, Suite 105
    Lakewood, New Jersey
      08701
    (Address of Principal Executive Offices)   (Zip Code)

     

    (732) 380-4600

    (Registrant’s Telephone Number, Including Area Code)

     

    N/A

    (Former Name or Former Address, if Changed Since Last Report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, par value $0.086 per share   EZRA   The NASDAQ Capital Market
    Series A Warrants to purchase shares of Common Stock, par value $0.086 per share   RELIW   The NASDAQ Capital Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 1.01. Entry into a Material Definitive Agreement.

     

    On February 5, 2026, Reliance Global Group, Inc. (the “Company”) entered into a Share Purchase Agreement (the “Share Purchase Agreement”) with Enquantum Ltd. (“Enquantum”), pursuant to which the Company has agreed to acquire, over time and subject to the satisfaction of specified milestone criteria and other conditions, an aggregate equity interest equal to 51% of Enquantum on a fully diluted basis (the “Target Ownership”). The transactions contemplated by the Share Purchase Agreement are structured to occur in an initial closing and subsequent milestone closings, each of which is subject to the satisfaction (or waiver) of customary closing conditions, including completion of the Company’s due diligence to its satisfaction.

     

    Under the Share Purchase Agreement, the aggregate purchase price to acquire the Target Ownership is $2,125,000, payable in tranches tied to specified monthly operational and commercialization milestones over an anticipated 10-month period. At the initial closing, the Company expects to acquire an 8% fully diluted ownership position in Enquantum, including (i) the conversion of a previously issued $166,000 secured bridge note into Enquantum ordinary shares representing 4% of Enquantum on a fully diluted basis and (ii) a cash-funded issuance representing an additional 4% fully diluted ownership. Thereafter, subject to the Company’s satisfaction of the applicable milestone criteria and other conditions, Enquantum is expected to issue additional ordinary shares to the Company in connection with monthly tranches generally designed to increase the Company’s fully diluted ownership by 4% per month through 48% fully diluted ownership.

     

    The Share Purchase Agreement also contemplates a final “control top-up” intended to increase the Company’s ownership from 48% to 51% of Enquantum on a fully diluted basis. As consideration for the control top-up, the Company has agreed to issue to Enquantum shares of the Company’s common stock, par value $0.086 per share (the “Common Stock”), with an aggregate value of $125,000, based on the last reported sale price of the Common Stock on The Nasdaq Stock Market LLC on the trading day immediately preceding the applicable control top-up closing.

     

    The foregoing description of the Share Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Share Purchase Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

     

     

     

     

    Item 3.02 — Unregistered Sales of Equity Securities

     

    In connection with the Share Purchase Agreement described under Item 1.01 above, the Company has agreed, subject to the satisfaction of specified milestone criteria and other closing conditions, to issue to Enquantum shares of the Company’s common stock, par value $0.086 per share (the “Common Stock”), with an aggregate value of $125,000 (the “Top-Up Shares”), as consideration for a final “control top-up” intended to increase the Company’s ownership in Enquantum from 48% to 51% on a fully diluted basis. The number of Top-Up Shares, if any, will be determined by dividing $125,000 by the last reported sale price of the Common Stock on The Nasdaq Stock Market LLC on the trading day immediately preceding the applicable control top-up closing. No Top-Up Shares have been issued as of the date of this Current Report on Form 8-K, and there can be no assurance that the conditions to the issuance of the Top-Up Shares will be satisfied or that any control top-up closing will occur.

     

    If issued, the Top-Up Shares are expected to be issued in reliance on an exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2) of the Securities Act and/or Regulation D thereunder, based on, among other things, representations and warranties to be made by the recipient(s) and the absence of any general solicitation in connection with such issuance. The Company will not receive any cash proceeds from the issuance of the Top-Up Shares.

     

    Item 7.01 Regulation FD Disclosure.

     

    On February 9, 2026, the Company issued a press release announcing the execution of the Share Purchase Agreement and describing the transactions contemplated thereby. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

     

    The information in this Item 7.01 and Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    Exhibit No.   Description
         
    10.1*   Share Purchase Agreement, entered into between the Company and Enquantum Ltd. Dated February 5, 2026
    99.1   Press Release, dated February 9, 2026
    104   Inline XBRL for the cover page of this Current Report on Form 8-K.

     

    * Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The omitted schedules and exhibits contain information that is not material and/or is of the type that the Company treats as private or confidential. The Company agrees to furnish supplementally a copy of any omitted schedule or exhibit to the Securities and Exchange Commission upon request.

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

     

      Reliance Global Group, Inc.
       
    Dated: February 10, 2026 By: /s/ Ezra Beyman
        Ezra Beyman
        Chief Executive Officer

     

     

    Get the next $EZRA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EZRA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $EZRA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Reliance Global Group Launches RELI Exchange 2.0 to Drive Faster, More Efficient Growth

    LAKEWOOD, NJ, March 25, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:EZRA) ("we," "us," "our," the "Company" or "Reliance") today announced the launch of RELI Exchange 2.0, the next phase of its InsurTech platform for independent insurance agencies, designed to expand recruiting capacity, improve execution and position the platform for faster, more efficient growth. In February 2026, Reliance reported that health insurance policies written through RELI Exchange during the 2025 open enrollment period increased 72% year over year, Personal Lines Property and Casualty written premium increased 36% year over year, and the broker network expanded from approximately 65 to approx

    3/25/26 8:50:00 AM ET
    $EZRA
    Specialty Insurers
    Finance

    Reliance Global Group Funds Next Enquantum Milestone, Increasing Ownership and Securing Additional Board Seat

    LAKEWOOD, NJ, March 19, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:EZRA) ("we," "us," our," the "Company" or "Reliance") today announced that it has funded the next completed milestone in its strategic investment in Enquantum Ltd., a post-quantum cryptography company developing quantum-resilient encryption technology for high-performance environments. We believe this milestone marks a significant step forward in Enquantum's commercialization strategy under the Scale51 execution plan, highlighted by continued advancement of its core technology and R&D capabilities, positioning the company for upcoming deployment activities. Enquantum is now actively engaging with prospect

    3/19/26 8:30:00 AM ET
    $EZRA
    Specialty Insurers
    Finance

    Reliance Global Group Reports 2025 Results and Provides Strategic Update on Scale51 Initiative and Launch of EZRA International Group

    Closing of Purchase Agreement in Post Quantum Cybersecurity Company Mark First Step in the Scale51 Technology Expansion Strategy Company to Host Conference Call Today at 4:30 PM Eastern Time LAKEWOOD, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: EZRA) ("we," "us," "our," the "Company" or "Reliance") today reported financial results for the year ended December 31, 2025, and provided a strategic update on the Company's Scale51 initiative, including the launch of EZRA International Group and the closing of the purchase agreement with Enquantum Ltd., a post quantum cybersecurity company. Scale51 represents the Company's structured framework for expanding into

    3/10/26 4:05:00 PM ET
    $EZRA
    Specialty Insurers
    Finance

    $EZRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Beyman Ezra

    4 - Reliance Global Group, Inc. (0001812727) (Issuer)

    3/26/26 4:45:01 PM ET
    $EZRA
    Specialty Insurers
    Finance

    SEC Form 4 filed by Markovits Joel

    4 - Reliance Global Group, Inc. (0001812727) (Issuer)

    3/24/26 9:25:27 PM ET
    $EZRA
    Specialty Insurers
    Finance

    SEC Form 4 filed by Reliance Global Group Inc.

    4 - Reliance Global Group, Inc. (0001812727) (Issuer)

    3/12/26 9:37:30 PM ET
    $EZRA
    Specialty Insurers
    Finance

    $EZRA
    SEC Filings

    View All

    Reliance Global Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Reliance Global Group, Inc. (0001812727) (Filer)

    3/27/26 6:15:07 AM ET
    $EZRA
    Specialty Insurers
    Finance

    Amendment: SEC Form 10-K/A filed by Reliance Global Group Inc.

    10-K/A - Reliance Global Group, Inc. (0001812727) (Filer)

    3/26/26 4:05:31 PM ET
    $EZRA
    Specialty Insurers
    Finance

    SEC Form DEF 14A filed by Reliance Global Group Inc.

    DEF 14A - Reliance Global Group, Inc. (0001812727) (Filer)

    3/23/26 9:00:42 AM ET
    $EZRA
    Specialty Insurers
    Finance

    $EZRA
    Financials

    Live finance-specific insights

    View All

    Reliance Global Group Reports 2025 Results and Provides Strategic Update on Scale51 Initiative and Launch of EZRA International Group

    Closing of Purchase Agreement in Post Quantum Cybersecurity Company Mark First Step in the Scale51 Technology Expansion Strategy Company to Host Conference Call Today at 4:30 PM Eastern Time LAKEWOOD, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: EZRA) ("we," "us," "our," the "Company" or "Reliance") today reported financial results for the year ended December 31, 2025, and provided a strategic update on the Company's Scale51 initiative, including the launch of EZRA International Group and the closing of the purchase agreement with Enquantum Ltd., a post quantum cybersecurity company. Scale51 represents the Company's structured framework for expanding into

    3/10/26 4:05:00 PM ET
    $EZRA
    Specialty Insurers
    Finance

    Reliance Global Group Schedules Fourth Quarter 2025 Financial Results and Business Update Conference Call

    LAKEWOOD, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:EZRA) ("Reliance" or the "Company"), announced today that it will host a conference call Tuesday, March 10, 2026, at 4:30 PM Eastern Time to discuss financial results for the fourth quarter 2025 and provide a business update. The conference call will be available via telephone by dialing toll-free +1 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and entering access code 121907. A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2381/53733 or on the investor relations section of the Company's website, https://relianceglobalgroup.com/events-and-pr

    3/6/26 8:30:00 AM ET
    $EZRA
    Specialty Insurers
    Finance